Work

A Randomized, Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Zotarolimus- Versus Paclitaxel-Eluting Stents in De Novo Occlusive Lesions in Coronary Arteries

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: JACC: Cardiovascular Interventions

DOI: 10.1016/j.jcin.2008.08.010

Authors: Bernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, Flavio Ribichini, Philip Urban, Jeffrey J. Popma, Peter J. Fitzgerald, Donald E. Cutlip, David O. Williams, John Ormiston, Eberhard Grube, Robert Whitbourn, Lewis B. Schwartz

Institutions: Centre Cardiologique du Nord, Royal Brompton Hospital, Universitäts-Herzzentrum Freiburg-Bad Krozingen, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Hôpital de la Tour, Brigham and Women's Hospital, Stanford Medicine, Harvard University, Baim Institute for Clinical Research, Rhode Island Hospital, Auckland City Hospital, Helios Hospital Siegburg, St Vincent's Hospital Melbourne, Abbott (United States)

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Abbott Laboratories, Eli Lilly and Company, Sanofi, Boston Scientific Corporation

OpenAlex ID: W48986764

FWCI: 5.98

Cites: 46

Cited by: 33

Related to: 10